News | Latest Breaking News Stories & Headlines

Bayer said its crop science division saw an adjusted EBITDA gain of 33.5% to €629m

Bayer beats Q3 profit forecast on strong herbicide sale

Agriculture and pharmaceuticals company Bayer has today reported better-than-expected quarterly earnings as surging demand for its herbicides made up for a decline in sales of its stroke prevention pill Xarelto.

Business • 08 Nov 22

Bayer shares up after first trial win over Roundup

Shares in Bayer rose this morning after the German agricultural and pharmaceuticals firm won its first trial over claims its Roundup weedkiller causes cancer.

Business • 06 Oct 21

Bayer warns that the costs of its settlement over claims its Roundup weedkiller causes cancer would be higher

Bayer takes €9.25 billion writedown

Bayer took impairment charges of €9.25 billion and said the costs of its settlement over claims its Roundup weedkiller causes cancer would be higher as the burden from its takeover of Monsanto mounts.

Business • 03 Nov 20

Bayer said in April it has been served with cases from 52,500 US plaintiffs who blame Roundup and other glyphosate-based weedkillers for their cancer

Bayer makes progress in settlement talks over Roundup

Bayer said today it had made progress seeking a settlement over claims its glyphosate-based Roundup weedkiller causes cancer, after Bloomberg reported the company reached a verbal agreement on about 50,000 to 85,000 cases.

Business • 25 May 20

Bayer is widely expected to eventually settle to buy itself out of the glyphosate litigation wave

Number of glyphosate plaintiffs jumps to 42,700 - Bayer

Bayer said the number of US plaintiffs blaming its glyphosate-based weedkillers for their cancer mushroomed to 42,700 from 18,400 in July, raising the stakes in the group's efforts to reach a settlement.

Business • 30 Oct 19

The wave of lawsuits has crashed onto Bayer since its takeover of US seeds and pesticides maker Monsanto last year for $63 billion

Bayer facing 18,400 US cases over glyphosate

German pharmaceutical giant Bayer has said it is now targetted in some 18,400 US legal cases over glyphosate, a key herbicide ingredient that plaintiffs say caused grave illnesses like cancer.

Business • 30 Jul 19

Bayer paid $63 billion for Monsanto last year

US judge slashes Roundup jury award to $25.3m

A federal judge has cut a damages award Bayer owed a California man who blamed Roundup weed killer for his cancer, to $25.27m from $80.27m.

Business • 16 Jul 19

Bayer said in a statement that it was disappointed with the Roundup verdict and would appeal

Bayer stock falls on $2 billion award in Roundup trial

Shares in Bayer were down 5.9% today after a jury awarded more than $2 billion to a California couple in the largest US jury verdict against the company over allegations its Roundup weedkiller causes cancer.

Business • 14 May 19

Bayer has seen about €30 billion wiped off its market value since August

Bayer gets Monsanto profit boost but legal burden grows

German drug and farming supplies company Bayer has today posted a 45% gain in quarterly core earnings thanks to the acquisition of seed maker Monsanto.

Business • 25 Apr 19

Hoping to ditch Monsanto's reputation, Bayer has said it plans to drop the name from its products

Five things to know about Bayer and Monsanto

The second cancer victim in a year to win a surprise victory against US pesticide maker Monsanto raises the prospect of a flood of similar lawsuits, potentially leaving the firm's new German owner Bayer with a major case of buyer's remorse.

Business • 20 Mar 19

A wave of lawsuits has put pressure on Bayer since its $63-billion takeover of Roundup maker Monsanto last year

Investors flee Bayer after second Roundup trial blow

The threat to German chemical giant Bayer and subsidiary Monsanto from US litigation swelled today, when its share price plunged after a jury ruled weedkiller Roundup was a "substantial factor" in a man's cancer.

Business • 20 Mar 19

Roundup Pro 360 is banned in France from today

France bans weed-killer after court ruling

French authorities have banned the sale of a form of controversial weed-killer Roundup following a court ruling that regulators failed to take safety concerns into account when clearing the widely used herbicide.

Europe • 15 Jan 19

In 2015, the cancer unit of the WHO classified glyphosate as 'probably carcinogenic to humans'

US judge upholds Monsanto verdict but slashes award

A US judge has upheld a jury verdict against Bayer subsidiary Monsanto in a historic case regarding the cancer danger of some of its weed killer products, but slashed the punitive damages award.

World • 23 Oct 18

Bayer shares plunge 14% after Roundup cancer trial

Shares in Bayer have plunged more than 14% to their lowest in almost five years - wiping around $14 billion off the value of the company - after a California jury ordered the German company's subsidiary Monsanto to pay $289m in damages last week.

Business • 13 Aug 18

Russia's competition regulator has approved Bayer's planned takeover of Monsanto

Russian nod moves Bayer closer to Monsanto deal

Russia's competition regulator FAS has approved Bayer's planned takeover of Monsanto, the German drugs and crop chemicals maker said, as it enters the home stretch to closing the $62.5 billion deal.

Business • 20 Apr 18

The Bayer-Monsanto deal would create a company with a share of over a quarter of the world's seed and pesticides market

Bayer reaches deal with US for approval to buy Monsanto

The US Justice Department will allow German drugs and pesticides group Bayer to acquire Monsanto in a $62.5 billion deal, according to US media reports.

Business • 10 Apr 18

The Bayer-Monsanto deal is set to create a company with control of more than a quarter of the world's seed and pesticides market

Bayer wins EU approval for $62.5 billion Monsanto buy

German conglomerate Bayer has today won EU competition approval for its $62.5 billion buy of US peer Monsanto, the latest in a trio of mega mergers that will reshape the agrochemicals industry.

Business • 21 Mar 18

The proposed deal has triggered protests from environmental and farming groups worried about their market power

Bayer to win EU approval for $62 billion Monsanto deal

German drug and crop chemicals maker Bayer is set to win conditional European Union competition approval for its $62.5 billion bid for the world's biggest seed company Monsanto.

Business • 28 Feb 18

BASF is the world's third-largest maker of crop chemicals

BASF to buy seeds, herbicide businesses from Bayer

BASF has agreed to buy significant parts of Bayer's seed and herbicide businesses for €5.9 billion in cash, the two companies said today.

Business • 13 Oct 17

Monsanto reaffirms its ongoing earnings per share target and raised its gross profit outlook for its seeds and genomics unit

Monsanto profit tops expectations on soybean sales

Seeds and agrochemicals company Monsanto, which is being bought by Germany's Bayer, reported a stronger-than-expected quarterly profit as record US and Brazilian soybean plantings lifted seed sales.

Business • 28 Jun 17

Monsanto is in the process of being bought by Germany's Bayer for $66 billion.

Monsanto posts better than expected jump in Q2 profit

US seeds and agrochemicals company Monsanto today reported a better than expected quarterly profit, helped by strong demand for its soybean and corn seeds.

Business • 05 Apr 17

Bayer wants to combine its crop chemicals business with Monsanto's industry leading seeds business

Bayer confirms $66 billion takeover of Monsanto

German drugs and crop chemicals company Bayer has confirmed that it has closed a deal to buy US seeds firm Monsanto for $66 billion.

Business • 14 Sep 16

Bayer said it is now willing to offer over $65 billion to acquire the world's largest seeds company

Bayer sweetens Monsanto bid as talks continue

German pharmaceutical and crops manufacturer Bayer said its negotiations with Monsanto had advanced, and that it was now willing to offer over $65 billion to acquire the world's largest seeds company.

Business • 06 Sep 16

Monsanto said Bayer's bid of $125 per share was 'financially inadequate' to ensure a deal

Monsanto calls Bayer's raised bid 'insufficient'

US agrochemical giant Monsanto said today that an increased takeover bid from Germany's Bayer was still "insufficient," but that it remains open to talks to seal the transaction.

Business • 19 Jul 16

Bayer sweetens its $64 billion bid for Monsanto

Bayer sweetens offer for hesitant Monsanto

German drug and crop chemical group Bayer has announced details of a sweetened $64 billion bid for Monsanto as it tries to put the US seed company under pressure to engage further.

Business • 15 Jul 16